Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors
Abstract The microtubule inhibitor vincristine is currently used to treat a variety of brain tumors, including low-grade glioma and anaplastic oligodendroglioma. Vincristine, however, does not penetrate well into brain tumor tissue, and moreover, it displays dose-limiting toxicities, including perip...
Saved in:
Main Authors: | Michelle De Witt (Author), Alexander Gamble (Author), Derek Hanson (Author), Daniel Markowitz (Author), Caitlin Powell (Author), Saleh Al Dimassi (Author), Mark Atlas (Author), John Boockvar (Author), Rosamaria Ruggieri (Author), Marc Symons (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of intestinal helminthiasis: mebendazole only or mebendazole-pyrantel pamoate?
by: Wisman Dalimunthe, et al.
Published: (2007) -
Mebendazole vs. mebendazole-pyrantel pamoate for soil-transmitted helminthiasis infection in children
by: Fereza Amelia, et al.
Published: (2013) -
Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar
by: Albonico M., et al.
Published: (2003) -
Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
by: Barthelemy Diouf, et al.
Published: (2021) -
Vincristine-Induced Acrocyanosis and Erythema Pernio
by: Hayden T. Middleton, et al.
Published: (2023)